$RCUS News

Arcus Biosciences Announces Publication In Nature Describing New Research From The ARC-20 Study Showing Casdatifan HIF-2a Inhibition Deeply Suppresses Serum EPO And Extends Progression-Free Survival In Advanced Kidney Cancer

Arcus Biosciences, Inc. (RCUS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Arcus Biosciences, Inc. (RCUS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Slideshow

LifeSci Capital Initiates Coverage of Arcus Biosciences (RCUS) with Outperform Recommendation

Truist Securities Assumes Arcus Biosciences at Buy, Raises Price Target to $35

Newsflash: Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Have Been Trimming Their Revenue Forecasts

Morgan Stanley Maintains Equal-Weight on Arcus Biosciences, Raises Price Target to $22

Analyst Estimates: Here's What Brokers Think Of Arcus Biosciences, Inc. (NYSE:RCUS) After Its First-Quarter Report

Goldman Sachs Maintains Buy on Arcus Biosciences, Raises Price Target to $34

Arcus Biosciences, Inc. 2026 Q1 - Results - Earnings Call Presentation

Arcus Biosciences, Inc. (RCUS) Q1 2026 Earnings Call Transcript

Arcus (RCUS) Q1 2026 Earnings Call Transcript

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Beats Revenue Estimates

Arcus Biosciences (NYSE:RCUS) Q1 Loss Narrows But Revenues Miss Estimates; Focus Shifts to Kidney Cancer Drug Casdatifan

Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update

Arcus Biosciences Q1 EPS $(1.02) Misses $(0.93) Estimate, Sales $17.000M Miss $29.484M Estimate

Eton Pharmaceuticals (ETON) Surges 19.8%: Is This an Indication of Further Gains?

Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Should You Buy?

Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Arcus Biosciences: TIGIT In The Rearview Mirror, But Market Pricing A Bit Too Aggressively For Now